Table 4.
Outcomes of 125 patients with more than 1 positive culture for nontuberculous mycobacteria from 2000 to 2012.
| MABSC |
MAC |
Other NTM/co-infecteda |
||||
|---|---|---|---|---|---|---|
| 2–4 pos | ≥ 5 pos | 2–4 pos | ≥ 5 pos | 2–4 pos | ≥ 5 pos | |
| Number of patients | 23 | 34 | 17 | 19 | 16 | 16 |
| Median duration of infection, y | 1 | 5 | 1 | 3 | 2 | 6 |
| Received NTM treatment, n (%) b | 13/19 (68%) | 28/30 (93%) | 5/14 (36%) | 15/17 (88%) | 4/11 (36%) | 14/16 (88%) |
| Cleared infection, n (%) c | 8/15 (53%) | 5/31 (16%) | 10/17 (59%) | 8/19 (42%) | 8/16 (50%) | 8/16 (50%) |
| ESLD, all, n (%) | 5 (22%) | 9 (26%) | 1 (6%) | 4 (16%) | 3 (19%) | 2 (13%) |
| ESLD judged NTM related, n (%) | 1 (4%) | 8 (24%) | 0 | 3 (16%) | 1 (6%) | 2 (13%) |
a
32 patients who had NTM species other than MABSC and MAC or combinations of more than one NTM species.
b
Data missing for 18 patients.
c
11 patients excluded due to too recent infection, MABSC = M. abscessus complex, MAC = M. avium complex, IQR = Interquartile range, ESLD = end stage lung disease, defined as death or lung transplantation during the study period.